Clinical trial recruitment stands at the forefront of drug and medical device development for companies, yet it often ...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
Clark, Executive Director, Patient Innovation & Engagement, Global Medical and Scientific Affairs at Merck, about the ...
We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...
3hon MSN
Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, ...
Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...
The U.S. Securities and Exchange Commission said on Thursday that it charged Cassava Sciences and two of the company's former ...
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not ...
This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of ...
Aiming to expedite drug development, enhance the body of clinical evidence supporting new and existing therapies, and improve ...
ProJenX teamed with Unlearn to create digital twins of ALS patients as a placebo group in open-label extension of Phase 1 ...
The Pediatric Clinical Trials Office at Children’s of Alabama is helping lead the way in finding the best treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback